Kamal Hamed

Kamal Hamed

No más puestos en curso
65 años
Health Technology
Consumer Services

Perfil

Kamal Hamed currently works at Spero Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Hamed also formerly worked at Novartis, Inc., as Head-Therapeutic Area from 2005 to 2017, Basilea Pharmaceutica AG, as Head-Clinical Development & Medical Affairs from 2017 to 2022, and Lysovant Sciences, Inc., as Chief Medical Officer in 2022.
Dr. Hamed received his graduate degree from The Johns Hopkins University, Masters Business Admin degree from the University of South Florida, and doctorate degree from American University of Beirut.

Antiguos cargos conocidos de Kamal Hamed.

EmpresasCargoFin
SPERO THERAPEUTICS, INC. Director Técnico/Científico/I+D 01/08/2024
Lysovant Sciences, Inc.
Director Técnico/Científico/I+D 01/08/2022
BASILEA PHARMACEUTICA AG Director Técnico/Científico/I+D 01/02/2022
Corporate Officer/Principal 01/03/2017
Ver el detalle de la experiencia de Kamal Hamed.

Formación de Kamal Hamed.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

9

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Lysovant Sciences, Inc.